Mangoceuticals, Inc. Announces Percent Patent Filing For MGX-0024 Antiviral Technology To Include Inhibiting Respiratory Or Orally Acquired Virus Infection In Animals Or Birds
MANGOCEUTICALS, INC. ANNOUNCES PERCENT PATENT FILING FOR MGX-0024 ANTIVIRAL TECHNOLOGY TO INCLUDE INHIBITING RESPIRATORY OR ORALLY ACQUIRED VIRUS INFECTION IN ANIMALS OR BIRDS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.